NS3/4A Serine Protease Inhibitors for the Treatment of HCV: Design and Discovery of Boceprevir and Telaprevir-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NS3/4A Serine Protease Inhibitors for the Treatment of HCV: Design and Discovery of Boceprevir and Telaprevir

Published:2015-05-29 Issue: Volume: Page:295-324
ISSN:
Container-title:Structure-Based Design of Drugs and Other Bioactive Molecules
language:
Short-container-title:

Author:

Ghosh Arun K.,Gemma Sandra

Publisher

Wiley-VCH Verlag GmbH & Co. KGaA

Reference76 articles.

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome;Choo;Science,1989

2. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002;Armstrong;Ann. Intern. Med,2006

3. Global challenges in liver disease;Williams;Hepatology,2006

4. Hepatitis C virus directly acting antivirals: current developments with NS3/4A HCV serine protease inhibitors;Naggie;J. Antimicrob. Chemother,2010

5. Current drug discovery strategies for treatment of hepatitis C virus infection;Cheng;J. Pharm. Pharmacol,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP